Rock Creek Pharmaceuticals Inc  

(Public, NASDAQ:RCPI)   Watch this stock  
Find more results for NASDAQ:STSI
0.153
-0.007 (-4.08%)
Nov 28 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.15 - 0.16
52 week 0.14 - 1.42
Open 0.15
Vol / Avg. 284,853.00/1.04M
Mkt cap 29.87M
P/E     -
Div/yield     -
EPS -0.23
Shares 193.00M
Beta 2.79
Inst. own 21%
Nov 10, 2014
Q3 2014 Rock Creek Pharmaceuticals Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin - -363.52%
Operating margin - -360.17%
EBITD margin - -356.70%
Return on average assets -326.09% -155.00%
Return on average equity - -207.92%
Employees 25 -
CDP Score - -

Address

2040 Whitfield Avenue, Suite 300
SARASOTA, FL 34243
United States - Map
+1-804-5271970 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Rock Creek Pharmaceuticals Inc, formerly Star Scientific, Inc., is a pharmaceutical company. The Company is engaged primarily in the sale of nutraceutical dietary supplements and related cosmetic products and in pursuing ongoing research and development by the Company�s subsidiary, RCP Development, Inc. of related dietary supplements and pharmaceutical products.

Officers and directors

Michael John Mullan Ph.D., M.D. Chairman of the Board, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Christopher C. Chapman M.D., Jr. President, Director
Age: 61
Bio & Compensation  - Reuters
Park A. Dodd III Chief Financial Officer, Treasurer, Assistant Secretary
Age: 61
Bio & Compensation  - Reuters
Lee Musgrove Canaan Independent Director
Age: 57
Bio & Compensation  - Reuters
Benjamin M. Dent Independent Director
Age: 63
Bio & Compensation  - Reuters
Edward J. McDonnell Independent Director
Age: 69
Bio & Compensation  - Reuters
Scott P. Sensenbrenner Independent Director
Age: 45
Bio & Compensation  - Reuters
Thomas L. Wilson Independent Director
Age: 67
Bio & Compensation  - Reuters